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Abstract
Medullary thyroid carcinomas (MTC) constitute about 5 to 7 % of thyroid neoplasms. They
originate from parafollicular C-cells which can secrete adrenocorticotropic hormone (ACTH) and/
or corticotropin-releasing factor (CRF) in abnormally high concentrations, potentially causing
paraneoplastic Cushing's Syndrome (CS).
We report on a 42-year-old male patient with a ten year history of metastatic medullary thyroid
carcinoma suffering from paraneoplastic Cushing's Syndrome caused by ectopic hypersecretion of
ACTH and a simultaneous Cortisol producing adrenal metastasis.
Background
Medullary thyroid carcinoma (MTC) is relatively rare and
represents 3% to 10% of all thyroid carcinomas [1]. It is
the third most common of all thyroid cancers. This tumor
entity derives from parafollicular C-cells of the thyroid
which are of neural crest origin and secrete calcitonin, a
polypeptide hormone which is an excellent tumor marker
for diagnosis and post-surgical follow-up, as it represents
the biochemical activity of MTC [2-4].
MTC can occur both in genetic or sporadic form. The
genetic form can either be isolated or as part of multiple
endocrine neoplasia (MEN) type 2A- (Sipple-) or 2B-
(Gorlin-) syndrome. Independent from its form, humor-
ally mediated symptoms may rarely be associated with
MTC. The C-cells potentially produce peptides such as
adrenocorticotropic hormone (ACTH) and/or corticotro-
pin-releasing factor (CRF) in abnormally high concentra-
tions which may lead to paraneoplastic Cushing's
Syndrome (CS). Ectopic hypersecretion of ACTH leading
to paraneoplastic Cushing's Syndrome is a rare occurrence
in patients with MTC. Only 50 cases have been reported
before now [5-9].
Another possible cause for Cushing's Syndrome is an
adrenal gland tumor primary or as a metastasis [10]. The
combination of both in a single patient has not been
reported to date.
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Case presentation
We report on a 42-year-old male patient with a 10-year
history of MTC. He suffered from abdominal, retroperito-
neal, osseous, pulmonary and mediastinal metastases.
The patient underwent multiple tumor and metastases
resections within the past 10 years. He received a modified
radical neck dissection and a clearance of the upper medi-
astinum due to progressive tracheal compression. His
family history was unremarkable regarding any endo-
crinological or thyroid disease. Specifically, a familial
form of MTC was excluded. He suffered from strong per-
sisting diarrhea which could only be controlled with
opium medication (tinctura opii 60 drops/d).
Three weeks before referral to our unit he developed mul-
tiple episodes of strong muscular weakness which was
temporarily so extreme that it led to paralysis. He devel-
oped diabetes and laboratory values showed very low
potassium levels, necessitating continuous intravenous
potassium replacement. Additionally he had exorbitantly
high levels of calcitonin > 2000 pg/ml and low levels of
calcium (2.34 mmol/l). Laboratory findings revealed
hypercortisolism, with cortisol values > 630 ng/ml (nor-
mal range; 23–119 ng/ml). The ACTH values were ele-
vated > 470 ng/l (normal range; 6–30 ng/l). A CT-scan of
the head showed a normal pituitary gland, excluding a
pituitary tumor.
A dexamethasone short- and long-term suppression test
showed no decrease of cortisol or ACTH. The rare diagno-
sis of a secondary Cushing's Syndrome with ectopic
ACTH-production due to a metastasized MTC was estab-
lished.
An adrenostatical treatment with the maximum dose of
1200 mg ketoconazole per day was initiated. After three
weeks the metabolic situation of the patient did not
change. The high values of free cortisol in the urine per-
sisted (4,000 to 10,000 μg/d). He further developed per-
sisting low potassium levels and unstable blood glucose
values which were treated with up to 500 mmol potas-
sium/24 h and regular insulin up to 250 IE/24 h.
In order to further investigate the cause of this disordered
metabolism, a CT-scan of the abdomen was performed.
Besides abdominal, retroperitoneal, osseous, pulmonary
and mediastinal metastases a tumor in the left adrenal
gland of 2 cm in diameter was described (Fig. 1). Both
adrenal glands were hypertrophic with a diameter of 5 × 2
× 3 cm. In order to determine the cortisol and ACTH levels
in various veins of the body selective venous catheterisa-
tion was used to anatomically localize the ectopic ACTH-
production. All regions of the body revealed consistently
high values of ACTH (180 to 220 ng/l) and cortisol (580
to 630 ng/ml).
To eliminate the production of excess cortisol we per-
formed a bilateral endoscopic retroperitoneal adrenalec-
tomy. The bilateral hyperthrophy of the adrenal glands
was verified intraoperatively and the left adrenal gland
showed a tumor-like nodule. Both adrenal glands were
removed. Histopathologic findings showed a metastasis
in the left adrenal gland originating from the MTC. Imme-
diately after the operation a substitution of 200 mg hydro-
cortisol per day was started. Unfortunately the need for
potassium and insulin did not change as compared to the
levels substituted before the operation. After ten days the
hydrocortisol substitution was stopped for 8 h. As a con-
sequence the cortisol levels normalized. Therefore we
interpreted the high demand for potassium and insulin as
a result of the cortisol substitution. The level of hydrocor-
tisol substitution was reduced to 100 mg/d (intravenous)
and 4 × 20 mg/d for two days and then stopped again.
Postoperatively the patient developed a chest infection
and subsequently entered respiratory failure. He was
transferred to the intensive care unit, but despite aggres-
sive treatment, died a few days later.
Discussion
Cushing's Syndrome is a hormonal disorder caused by
prolonged exposure of the body's tissues to high levels of
cortisol. The most common cause of hypercortisolism
(80%) is a pituitary adenoma (Cushing's disease), which
was excluded in our patient [11]. Another possible cause
is ectopic ACTH- and/or CRH-Syndrome caused by
benign or malignant tumors originating outside the pitu-
itary gland (10–15%). This condition is described as
ectopic, paraneoplastic ACTH and/or CRH production
and is mostly induced by lung tumors (50%). The most
common forms of ACTH-producing tumors are oat cell or
small cell lung cancer which accounts for about 25% of all
lung cancer cases, and carcinoid tumors. In rare cases less
common types of tumors which are described causing
ectopic ACTH production are: pancreatic islet cell tumors,
thymomas, very rarely abdominal carcinoids, liver-, pros-
tate-, breast- or colon and medullary thyroid carcinomas.
Paraneoplastic, ectopic hypersecretion of ACTH is a very
rare occurrence in MTC, with only 50 cases reported.
MEN I can cause Cushing's Syndrome due to pituitary,
ectopic or adrenal tumors, and has to be diagnosed by
PCR genotype analysis when suspected. Other possible
causes of CS are adrenal gland tumors which often lead to
rapid development of clinical symptoms. Most of these
cases involve adrenal adenomas. Adrenal cancers, primary
or as metastasis are one of the least common causes of
Cushing's Syndrome [12].
Cushing's Syndrome and, much more frequently, patients
receiving exogenous glucocorticoid therapy (after adrena-
lectomy for example), are especially at risk of infections.International Seminars in Surgical Oncology 2007, 4:15 http://www.issoonline.com/content/4/1/15
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The same is true for patients with ectopic ACTH-produc-
tion which potentially leads to extensive hypercortisolism
as in our patient. This vulnerability is attributed to the
complex dysregulation of immunity caused by glucocorti-
coids [13]. The cytotoxic T-lymphocyte type 1: type 2 ratio
is impaired which makes patients prone to serious oppor-
tunistic infections [14].
In the author's point of view it is important to be aware of
early clinical and laboratory signs of ectopic Cushing's
Syndrome and further initiate laboratory and radiologic
examinations determining the causes of excess levels of
cortisol.
The diagnosis of paraneoplastic CS is based on hypercor-
tisolism with normal or high levels of plasma ACTH and
elevated lipotropic pituitary hormone (LPH), which is not
suppressed by low-dose dexamethason suppression, and
the absence of pituitary adenoma as seen in pituitary MRI.
Both were the case in our patient. Uncommonly, the diag-
nosis is confirmed by immunohistochemical techniques
or by proopiomelanocortin mRNA in situ hybridization
of MTC tissue.
Therapy is either conservative or surgical. Somatostatin
analogues, metyrapone, aminoglutethimide, etomidate
and ketoconazol are among the medications described in
the literature [15,16]. The indication for bilateral adrena-
lectomy, however, should be discussed early in the dis-
ease. As in our patient a conservative form of therapy was
ineffective and valuable time was lost before we made the
diagnosis of an adrenal gland metastasis.
Surgical treatment of the patient's cancer may lead to cure.
However, in patients with advanced disease and metas-
tases, as was the case described, the early diagnosis of CS
would be of strong value as specific treatment of hypercor-
tisolism including bilateral adrenalectomy, can be initi-
ated early, before the impact on the patient's immunity
leads to serious complications.
Persistent diarrhea has been described as a symptom of
MTC [17]. This phenomenon is possibly linked to the
involvement of calcitonin gene-related peptide (CGRP)
which has been shown to induce colonic fluid secretion in
the rat colon with an increased secretion of sodium, potas-
sium, and chloride [18,19]. The extent to which the latter
observation can be valid for humans has yet to be investi-
gated.
Conclusion
In order to decrease the likeliness of infection and
improve survival it would be beneficial to screen patients
with MTC for early signs of a developing CS. Although it
is extremely rare it has to be kept in mind that in cases
when conservative forms of therapy show no effect, a sec-
ond cause for the abnormally high cortisol values, such as
an adrenal gland tumor is possible and should be
excluded.
However, in the context of our patients' disseminated
metastases, it can not be finally assessed if his adrenal
metastasis was an incidental finding or conclusively
responsible for the CS. Bearing in mind that our patient
developed his severe symptoms over a short period of
time after 10 years of disease makes the adrenal gland
metastases the most likely cause for CS. An earlier recog-
nition and treatment of CS should help in prevention of
opportunistic infections by potentially decreasing the
fatal impact of hypercortisolism on the patient's immu-
nity.
Abdominal CT scan demonstrating the horizontal (a), coronal (b) and sagittal (c) section of a tumor in the left adrenal gland  (circle) Figure 1
Abdominal CT scan demonstrating the horizontal (a), coronal (b) and sagittal (c) section of a tumor in the left adrenal gland 
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